Invention Grant
- Patent Title: Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodies
-
Application No.: US15343447Application Date: 2016-11-04
-
Publication No.: US09856326B2Publication Date: 2018-01-02
- Inventor: Con Panousis , Veronika Rayzman , Andrew Nash , Michael Wilson , Stefan Schmidbauer , Marc Nolte
- Applicant: CSL Behring GmbH , CSL Ltd.
- Applicant Address: DE Marburg AU Parkville
- Assignee: CSL Behring GmbH,CSL Ltd.
- Current Assignee: CSL Behring GmbH,CSL Ltd.
- Current Assignee Address: DE Marburg AU Parkville
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Priority: EP11175105 20110722; EP12153310 20120131
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/40 ; A61K39/00
Abstract:
The invention relates to inhibitory anti-factor XII/FXIIa antibodies and methods of their use.
Public/Granted literature
- US20170137536A1 INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL ANTIBODIES AND THEIR USES Public/Granted day:2017-05-18
Information query
